Lauder Looks to Bring Clinique, Estee Lauder To ‘Full Speed’ In H2
This article was originally published in The Rose Sheet
Identifying its luxury and makeup artistry brands as second-quarter growth drivers, the Estee Lauder Companies says it will put more resources behind its core Estee Lauder and Clinique brands in the second half of fiscal 2015. The firm’s sales for the quarter inched up 1% on a reported basis to $3.04 billion.
You may also be interested in...
Growth opportunities exist for firms marketing home-use skin-care devices and cosmeceuticals in new categories such as hair care, but such products also can invite regulatory scrutiny for exceeding FDA’s definition of a cosmetic. Consulting with FDA on a premarket basis and crafting claims with attention to regulatory parameters can help firms stay in the agency’s good graces.
The Department of Toxic Substances Control does not identify specific chemicals of concern in its 2021-2023 Priority Product Draft Work Plan, but says it is focusing on ingredients and endpoints associated with children, women of childbearing age, communities of color and aquatic impacts.
Women’s Voices for the Earth says California’s Cleaning Product Right to Know Act, which influenced similar legislation enacted last year for cosmetic fragrance and flavor ingredients, has revealed toxic substances long hidden from the general public that disproportionately impact marginalized groups.